Advanced Oncotherapy presents at the UK Investor Magazine Virtual Investor Conference July 2022.

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient’s healthy tissues.

Download slides here

Previous articleFTSE 100 dips as inflation hits 9.4% and EU warns on Russia gas
Next articleSSE performs slightly above expectations in Q1, SSEN Transmission disposal eyed for end of 2023
This is the profile of the UK Investor Magazine team who, in collaboration with each other and our partners, produce a number of in-depth analytical articles, reviews of investment services and publish sponsored articles from carefully selected partners.